BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma

Clinical trial NCT04162353 · RECRUITING

Trial details

NCT number: NCT04162353
Sponsor: iCell Gene Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Refractory Multiple Myeloma Plasmacytoid; Lymphoma

Start date: 2019-07-01
Primary completion: 2026-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.